You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盤龍藥業(002864.SZ)獨家品種盤龍七片納入國家藥品目錄甲類範圍
格隆匯 08-21 17:21

格隆匯8月21日丨盤龍藥業(002864.SZ)公佈,近日,國家醫療保障局、人力資源社會保障部發布了《關於印發 <國家基本醫療保險、工傷保險和生育保險藥品目錄> 的通知》(醫保發〔2019〕46號),公佈了《國家基本醫療保險、工傷保險和生育保險藥品目錄(2019年版)》。公司獨家品種盤龍七片納入國家藥品目錄甲類範圍。

盤龍七片為公司獨家生產品種,是由二十九味中草藥組成,其中盤龍七、壯筋丹、過山龍、珠子參等十三味稀有道地藥材,均為生長在秦巴山區海拔1,800米以上的獨有的天然名貴中草藥。曾入選中藥保護品種,功能主治為活血化瘀、消腫止痛、祛風除濕,用於風濕性關節炎、腰肌勞損、軟組織損傷、骨折等病症所表現的疼痛、腫脹、麻木、活動受限均具有顯著的治療效果。

此次獨家品種盤龍七片納入國家藥品目錄甲類範圍,將使風濕性關節炎及骨傷等病症患者獲益,有利於公司產品市場佈局的拓展以及市場份額的進一步擴大,對公司長遠發展具有積極作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account